Idexx LaboratoriesIDXX
About: Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
Employees: 11,000
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
20% more first-time investments, than exits
New positions opened: 103 | Existing positions closed: 86
0% more funds holding
Funds holding: 1,092 [Q2] → 1,096 (+4) [Q3]
2% less capital invested
Capital invested by funds: $37.4B [Q2] → $36.5B (-$835M) [Q3]
4.21% less ownership
Funds ownership: 92.88% [Q2] → 88.67% (-4.21%) [Q3]
14% less funds holding in top 10
Funds holding in top 10: 14 [Q2] → 12 (-2) [Q3]
17% less repeat investments, than reductions
Existing positions increased: 352 | Existing positions reduced: 425
46% less call options, than puts
Call options by funds: $95M | Put options by funds: $176M
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
Barclays Balaji Prasad 38% 1-year accuracy 15 / 40 met price target | 13%upside $520 | Overweight Maintained | 4 Feb 2025 |
B of A Securities Michael Ryskin 75% 1-year accuracy 3 / 4 met price target | 16%upside $535 | Neutral Maintained | 4 Feb 2025 |
Morgan Stanley Erin Wright 64% 1-year accuracy 18 / 28 met price target | 20%upside $550 | Overweight Maintained | 29 Jan 2025 |
Leerink Partners Daniel Clark 50% 1-year accuracy 1 / 2 met price target | 9%upside $500 | Outperform Initiated | 2 Dec 2024 |
Financial journalist opinion
Based on 16 articles about IDXX published over the past 30 days









